XML 69 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of Equity Compensation Plan Information

Equity Compensation Plan Information as of December 31, 2021:

 

   Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)   Weighted – average exercise price of outstanding options, warrants and rights (b)   Number of securities remaining available for future issuances under equity compensation plans (excluding securities reflected in column (a) (c) 
Equity Compensation Plans Approved by Security Holders   2,125,000   $.0434    22,875,000 
Equity Compensation Plans Not Approved by Security Holders            
Total   2,125,000   $.0434    22,875,000 
Schedule of Option Activity

A summary of the Company’s stock option as of December 31, 2021 and 2020, and changes during the years ended December 31, 2021 and 2020 is presented below:

 

           Weighted     
       Weighted   Average    
      Average   Remaining   Aggregate 
   Number of
Options
   Exercise
Price
   Contractual
Life in Years
   Intrinsic
Value
 
Outstanding at December 31, 2019   35,295,237   $0.018    4.58      
Granted   164,434,783    0.0354           
Forfeited   -    -           
Exercised   -    -           
Cancelled       -          
Outstanding – December 31, 2020   199,730,020   $0.0323    2.84      
Exercisable – December 31, 2020   44,730,020   $0.0185    3.59   $168,892 

 

           Weighted     
       Weighted   Average    
      Average   Remaining   Aggregate 
   Number of
Options
   Exercise
Price
   Contractual
Life in Years
   Intrinsic
Value
 
Outstanding at December 31, 2020   199,730,020   $0.0323    2.84      
Granted   33,473,246    0.0430           
Forfeited   (75,000)   0.0360           
Exercised   -    -           
Cancelled   -    -           
Outstanding – December 31, 2021   233,128,266   $0.0362    2.23      
Exercisable – December 31, 2021   76,068,249   $0.0284    2.30   $795,201 
Schedule of Warrants Activity

A summary of the Company’s warrants as of December 31, 2021 and 2020, and changes during the years ended December 31, 2021 and 2020 is presented below:

 

           Weighted     
       Weighted   Average    
      Average   Remaining    
   Number of Warrants   Exercise Price   Contractual Life in Years   Aggregate Intrinsic Value 
Outstanding at December 31, 2019   52,608,725   $0.01    4.58      
Granted   -    -           
Forfeited   -    -           
Exercised   (22,500,000)   0.01           
Cancelled   (30,108,725)   0.0115           
Outstanding – December 31, 2020   -   $-    -      
Exercisable – December 31, 2020   -   $-    -   $- 

 

           Weighted     
       Weighted   Average    
      Average   Remaining    
   Number of Warrants   Exercise Price   Contractual Life in Years   Aggregate Intrinsic Value 
Outstanding at December 31, 2020   -   $-    -      
Granted   14,600,000    0.0250           
Forfeited   -    -           
Exercised   -   -           
Cancelled      -           
Outstanding – December 31, 2021   14,600,000   $0.0250    

1.67

      
Exercisable – December 31, 2021   14,600,000   $0,0250    1.67   $153,300